COMMUNIQUÉS West-GlobeNewswire

CalMHSA Selects Eleos as Statewide AI Technology Partner for Behavioral Health
11/02/2026
Eleos’ AI platform pairs with Streamline Healthcare Solutions’ EHR in counties across California, supporting enhanced human connection in behavioral health care delivery BOSTON and OAK BROOK, Ill. and SACRAMENTO, Calif [...]
Soleno Therapeutics to Report Fourth Quarter and Full-Year 2025 Financial Results on February 25, 2026, at 4:30 PM ET
11/02/2026
REDWOOD CITY, Calif., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced [...]
Psyence BioMed Announces Settlement of Shareholder Litigation
11/02/2026
NEW YORK, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (" Psyence BioMed " or the " Company ") today announced that it has entered into a settlement agreement to resolve a direct shareholder [...]
Entera Bio Announces Open Market Purchases of Company Stock by Board Members
11/02/2026
TEL AVIV, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX) ("Entera" or the "Company"), a leader in the development of oral peptide and protein replacement therapies, today announced that several members [...]
Senti Biosciences Completes Enrollment in Phase 1 Clinical Trial of SENTI-202 for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia (R/R AML)
11/02/2026
Robust SENTI-202 clinical data presented at ASH 2025 demonstrated deep, MRD-negative, durable complete remissions and a favorable safety profile Company planning for rapid advancement of SENTI-202 into R/R AML pivotal [...]
DIL Walk Foundation Takes National and Global Leadership Role in Advancing Precision Health and Healthspan
11/02/2026
CALGARY, Alberta, Feb. 11, 2026 (GLOBE NEWSWIRE) -- The DIL Walk Foundation is strengthening its leadership role in advancing precision health, longevity research, and healthspan-focused care, positioning Canada as an [...]
VIVUS Advances Patient Access with New Copay Assistance Program for PANCREAZE®
11/02/2026
— Commercially-insured patients can pay as little as $0 on their copay and up to $2,000 per fill for their PANCREAZE ® prescription CAMPBELL, Calif., Feb. 11, 2026 (GLOBE NEWSWIRE) -- VIVUS LLC, a biopharmaceutical [...]
Wesley Pharmaceuticals Launches NAD+, Introducing a Signature Longevity and Skin Health Formulation to Its Product Lineup
11/02/2026
The premier 503B facility streamlines clinical access to its flagship NAD+ injection, offering an innovative wellness solution for Wesley’s nationwide client base ORLANDO, Fla., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Wesley [...]
Gelteq and Healthy Extracts to Expand Gel-Based Nutrition Technologies with New Strategic Manufacturing & Commercial Partnership
11/02/2026
MELBOURNE, Australia and LAS VEGAS, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Gelteq Limited (“Gelteq”) and Healthy Extracts™ Inc. (“Healthy Extracts”) today announced the signing of a Memorandum of Understanding (“MoU”) [...]
PolyPid Provides Corporate Update and Reports Fourth Quarter and Full-Year 2025 Financial Results
11/02/2026
The Company is in Advanced Stage s of Commercial U.S. Partner ship Discussions for D-PLEX₁₀₀ Positive FDA Pre-NDA Feedback Supports Rolling NDA Review ; Submission Expected to Begin by the E nd of the First Quarter of [...]
Akari Therapeutics Participates in Virtual Investor “What This Means” Interview Discussing the Company’s Expanded ADC Pipeline
11/02/2026
CEO Abizer Gaslightwala discusses the Company’s recent announcement around its ADC pipeline expansion and IP strategy Company also discusses its lead ADC program, AKTX-101, and its planned IND and CTA submissions as it [...]
Dewpoint Therapeutics Selects First-in-Class MYC Condensate Modulator Development Candidate
11/02/2026
• First MYC condensate-modulating small molecule advanced to Development Candidate • Demonstrates potent, selective inhibition of MYC-driven transcription via condensate modulation • Preclinical data support potential [...]
LeMaitre Will Announce Fourth Quarter 2025 Earnings Results February 25, 2026
11/02/2026
BURLINGTON, Mass., Feb. 11, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its fourth quarter 2025 financial results on Wednesday, February 25, 2026, after the market [...]
AIM ImmunoTech Announces Commencement of Rights Offering
11/02/2026
OCALA, Fla., Feb. 11, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) – AIM ImmunoTech Inc. (“AIM” or the “Company”), an immuno-pharma company focused on the research and development of its lead [...]
Coloplast A/S - Updated Financial Calendar 2025-26
11/02/2026
Please see enclosed pdf. Update to Financial Calendar Dates Coloplast has updated the dates in its financial calendar for the publication of the FY Financial Statements 2025/26 and the Annual General Meeting 2026. The [...]
HealthEdge® Achieves HITRUST Risk-based, 2-year Certification to Manage Risk, Improve Security Posture, and Meet Compliance Requirements
11/02/2026
FRISCO, Texas and BOSTON, Feb. 11, 2026 (GLOBE NEWSWIRE) -- HealthEdge ® , the technology and services company powering health plans’ most important value streams, today announced that it has achieved HITRUST r2 [...]
INVO Fertility Announces Patent Issuance for Modified INVOcell® Device
11/02/2026
New patent extends intellectual property protection on the Company’s INVOcell device through 2040 SARASOTA, Fla., Feb. 11, 2026 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO” or the “Company”), a [...]
Counslr Meets School Mental Health Demands with Further National Expansion and Strategic Partnerships
11/02/2026
Text-based support Signals a Shift in School Mental Health Access NEW YORK, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Counslr , a leading B2B mental health and wellness platform , announced today a series of strategic [...]
Telehealth Now Available for DARE to PLAY™ Sildenafil Cream: First Evidence-Based Topical Arousal Cream for Women
11/02/2026
Pre-Fulfillment Prescribing Now Available in All 50 States, Supporting National Launch Developed and evaluated specifically for women, DARE to PLAY™ Sildenafil Cream is a first-of-its-kind female arousal cream, a non- [...]

Pages